...
首页> 外文期刊>Journal of plastic surgery and hand surgery. >Basosquamous carcinoma: Is it an aggressive tumor?
【24h】

Basosquamous carcinoma: Is it an aggressive tumor?

机译:鳞癌:它是侵袭性肿瘤吗?

获取原文
获取原文并翻译 | 示例
           

摘要

Basosquamous carcinoma is a rare cutaneous tumour that is considered an aggressive type of basal cell carcinoma with an increased risk of recurrence and metastases. This impression has been perpetuated in the literature, despite limited scientific data and conflicting results of some authors. This present study was aimed to evaluate the clinical-pathological features of this tumour and follow-up of a series of basosquamous carcinoma. Basosquamous carcinoma patients who underwent surgical excision between January 2000 and February 2012 were analyzed retrospectively. Their medical files were reviewed and the corresponding routinely stained sections (with hematoxylin-eosin) were re-evaluated by two pathologists. Thirty-five patients with basosquamous carcinoma were operated on in this period. Most tumurs were located in the head and neck area (94%), and the mean age of the patients was 69.8 years. Margin involvements were seen in 11 patients (31.4%) and all of them underwent re-excision. There was only one local recurrence. There was neither regional lymph node nor distant metastasis in this series. The recurrence rate of basosquamous carcinoma is found as 4%, lower than that of most other similar studies. Further pathologic studies are needed to better classify basosquamous carcinoma and to increase consistency between the results of studies. Surgical excision and regular follow-up are considered as the treatment of choice.
机译:基底鳞癌是一种罕见的皮肤肿瘤,被认为是侵袭性类型的基底细胞癌,其复发和转移的风险增加。尽管科学数据有限且某些作者的结果相矛盾,但这种印象在文献中一直存在。本研究旨在评估该肿瘤的临床病理特征和一系列鳞状鳞癌的随访。回顾性分析2000年1月至2012年2月进行手术切除的巴斯克鳞癌患者。审查了他们的医学档案,并由两名病理学家对相应的常规染色切片(苏木精-曙红)进行了重新评估。在此期间对35例鳞状上皮癌患者进行了手术。大多数肿瘤位于头颈部区域(94%),患者的平均年龄为69.8岁。 11例患者(31.4%)可见边缘受累,所有患者均再次切除。仅局部复发。该系列既无区域淋巴结转移,也无远处转移。发现基底鳞​​癌的复发率为4%,低于大多数其他类似研究的复发率。需要进行进一步的病理学研究,以更好地对基底鳞癌进行分类,并提高研究结果之间的一致性。手术切除和定期随访被认为是治疗的选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号